Home > Clinical Trials
Check All Search

Saved trials

Completed
NCT04459598
A Study of the Effect of a Moderate CYP3A Inducer Efavirenz on Quizartinib Pharmacokinetics in Healthy Participants
32 Enrollment(s)
1 Study location(s)
Interventional (Phase I)
Healthy Subjects
Drug-drug Interaction
Pharmacokinetics
Quizartinib
Recruiting
NCT05320627
Population Pharmacokinetics of Edoxaban in Chinese Patients With Non-Valvular Atrial Fibrillation
120 Enrollment(s)
1 Study location(s)
Interventional (Phase IV)
Non-Valvular Atrial Fibrillation
Completed
NCT04608344
Study to Evaluate Organic Anion Transporting Polypeptide (OATP) Transporter-Mediated Drug-Drug Interactions Between Filgotinib and Statins as Probe Drugs in Healthy Participants
27 Enrollment(s)
1 Study location(s)
Interventional (Phase I)
Rheumatoid Arthritis
Completed
NCT01536964
The Effect of Morphine on Prasugrel Absorption in STEMI Patients
12 Enrollment(s)
1 Study location(s)
Interventional (Phase IV)
Cardiovascular Disease
Terminated
NCT04209725
A Study of CPX-351 (Vyxeos™) With Quizartinib for the Treatment of FLT3-ITD Mutation-Positive Acute Myeloid Leukemia
1 Enrollment(s)
5 Study location(s)
Interventional (Phase II)
Leukemia, Myeloid, Acute
Completed
NCT02944019
Edoxaban Treatment in Routine Clinical Practice for Patients With Non Valvular Atrial Fibrillation
13,980 Enrollment(s)
724 Study location(s)
Observational
Atrial Fibrillation
Completed
NCT05022563
Treatment Patterns and Bleeding Risk of Anticoagulants in Patients With Venous Thromboembolism in Korea
100,000 Enrollment(s)
2 Study location(s)
Observational
Venous Thromboembolism
Withdrawn
NCT04676243
Daunorubicin or Idarubicin With Cytarabine Plus Quizartinib vs Physician's Choice in Newly Diagnosed FLT3-ITD+ AML
0 Enrollment(s)
0 Study location(s)
Interventional (Phase III)
Acute Myeloid Leukemia